Liposomal Bupivacaine Versus Lidocaine for Skin Graft Donor Site Pain

Completed · Phase 4

Conditions studied: Pain, Postoperative, Burns

In brief

Donor site pain study comparing post-operative donor site pain and opioid consumption after use of Lidocaine, Liposomal Bupivicaine or regional nerve block for split thickness skin graft harvesting in patients with less than 20% TBSA burn wounds and less than %5 Deep partial or full thickness burn wounds.

Key facts

Study ID

NCT03854344

Run by

University of Kansas Medical Center

People needed

74

Starts

2019-03-18

Expected to finish

2025-10-27

Last updated by the study team

2026-03-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Spanish/English speaking
• <20%TBSA; <5% TBSA deep partial or full thickness burns

You may not qualify if…

• chronic pain syndrome
• > 20% TBSA burn injury; > 5% TBSA deep partial or full thickness burn
• pregnant
• allergy to lidocaine or other local anesthetics
• burns to anterior thighs

Where it is running

• The University of Kansas Health System — Kansas City, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.